Kohzuki M, Johnston C I, Chai S Y, Jackson B, Perich R, Paxton D, Mendelsohn F A
Melbourne University Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
J Hypertens. 1991 Jul;9(7):579-87. doi: 10.1097/00004872-199107000-00001.
Angiotensin converting enzyme (ACE) inhibitors lead to induction of ACE in animals and humans. This complicates the use of ACE enzymatic activity as an index of inhibition in plasma or tissues after chronic administration of ACE inhibitors. We have, therefore, developed a method for ACE measurement by in vitro autoradiography using an 125I-labelled inhibitor to quantitate total ACE and the concentration of free (not inhibited) ACE in tissues after prolonged administration of ACE inhibitors to rats. Measurements made on unprocessed tissue sections reflect residual free ACE activity in the presence of the unlabelled inhibitor. In a parallel series of adjacent sections, the ACE inhibitor is dissociated from the enzyme by reversibly denaturing the enzyme by zinc chelation. This is followed by reconstitution of the active enzyme by zinc ion replacement and measuring total enzyme concentration. This technique permits measurement of the extent of ACE inhibition and induction. This method was evaluated in tissues of rats following chronic oral administration of lisinopril (10 mg/kg per day) for 2 weeks. The pattern of ACE inhibition was similar to that seen in our previous acute studies. However, induction of ACE was found to be organ specific; plasma total ACE increased 1.75-fold and total ACE in the lung increased by 30% compared with untreated animals, but there was no demonstrable change in total ACE concentration in the kidney, adrenal or aorta. Despite this, during chronic treatment with lisinopril, ACE activity in all of these organs was inhibited with low levels of free ACE.(ABSTRACT TRUNCATED AT 250 WORDS)
血管紧张素转换酶(ACE)抑制剂会导致动物和人类体内ACE的诱导。这使得在长期给予ACE抑制剂后,将ACE酶活性作为血浆或组织中抑制作用指标的应用变得复杂。因此,我们开发了一种通过体外放射自显影测量ACE的方法,使用125I标记的抑制剂来定量大鼠长期给予ACE抑制剂后组织中的总ACE和游离(未被抑制)ACE的浓度。对未处理的组织切片进行的测量反映了在未标记抑制剂存在下的残余游离ACE活性。在一系列相邻的平行切片中,通过锌螯合使酶可逆变性,从而使ACE抑制剂与酶解离。随后通过锌离子置换重建活性酶并测量总酶浓度。该技术允许测量ACE抑制和诱导的程度。在大鼠经口服赖诺普利(每天10mg/kg)慢性给药2周后的组织中对该方法进行了评估。ACE抑制模式与我们之前的急性研究中所见相似。然而,发现ACE的诱导具有器官特异性;与未处理的动物相比,血浆总ACE增加了1.75倍,肺中的总ACE增加了30%,但肾脏、肾上腺或主动脉中的总ACE浓度没有明显变化。尽管如此,在赖诺普利慢性治疗期间所有这些器官中的ACE活性均受到抑制,游离ACE水平较低。(摘要截短于250字)